Genetic testing company 23andMe’s bankruptcy filing in March looked like a glum end to a short, troubled life. The stock had crashed from a peak of $320 in 2021 to less than $2 in March. Losses were mounting, and cash was running out fast.
基因檢測公司23andMe公司於今年3月申請破產，這似乎爲其短暫而多舛的歷程畫上了黯淡的句號。該公司股價自2021年高點的320美元暴跌至今年3月的不足2美元。虧損不斷擴大，現金也迅速枯竭。
您已閱讀8%（334字），剩餘92%（3614字）包含更多重要資訊，訂閱以繼續探索完整內容，並享受更多專屬服務。